Taking it to the streets. Stockhouse.com: Taking it to the street
Stem Cell Therapeutics Corp is engaged in developing stem cell therapeutic technologies through partnerships with academic and research institutions across Canada and abroad.
Price Change % Change Volume Day High/Low 52 Week High/Low
post non-threaded view
subject user date & time rating

Stem Cell Therapeutics Closes $3.1 Million FinancingTORONTO, ONTARIO--(Marketwire - March 15, 2013) -NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S.NEWSWIRE SERVICESStem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT&...
3/15/2013 10:05:00 AM

What do you guys think should I pick up some shares at the current market price @ 20 cents or pick up the shares from the prospectus @ 25 cents but I get the warrent option...
3/12/2013 11:23:47 AM

Man o Man. The Volume is amazing really. This isn't pennies. Who is moving these blocks? We are now under .2 or .o2..That vol. x 10 is our old function before rs.. what has caused the buy sell since prior to rs.. I don't think it's li...
3/11/2013 11:08:25 AM 4

-Long Live SSS Still above .02 cents/ .20
3/9/2013 10:03:40 AM

looks like the race to lower lows is now in full force.......could it end up at two pennies again
3/8/2013 4:24:45 PM 1

I'm pretty new around here.. When does it get announced that this offering is filled. Is everyone able to buy into this prospectus sale? Am i missing something.? Is this valued at .25 cents now? i guess peace
3/8/2013 11:03:52 AM 1

Nice opportunity. Nice Volume lately. GLTA Peace. Thanks all for yur posts.
3/8/2013 10:49:40 AM

we just did a reverse split of 10-1....now we dilute it...how long will it take to get the share count back to where it was? just sayin........I guess there was no other way to get the cash....had to consolidate first to offer up shares later. Le...
3/7/2013 7:05:52 PM 4

Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT"), a life sciences company developing stem cell-related technologies, announced today that it intends to file a prospectus supplement in each of the Canadian provinces of British Colu...
3/7/2013 6:11:51 PM 3

Stem Cell Therapy Moves to Reinvent Itself, Raise Value By Brian Orelli BioWorld Insight Contributing Writer After seeing its clinical program stall following the failure of a Phase IIb trial testing NTx-265 in acute stroke, Stem Cell Therapeutic...
3/5/2013 8:38:22 PM 4

nice candle too
3/5/2013 10:08:14 AM

RTQ Depth? Can we go through a dollar? Or should I say .10. ;)
2/25/2013 11:12:39 AM 1

David Allan is lead director at DiaMedica, the founding chairman, and previous CEO of the public company, YM BioSciences , Executive Chairman of the public company Stem Cell Therapeutics Corp., and chairman of the private, Canadian company, AvidB...
2/23/2013 8:09:21 PM 2

DiaMedica (TSX VENTURE:DMA) announces today that David Allan has resigned from the Company
2/22/2013 11:28:40 PM 1
hmm

who was asking when to buy? the choice isnt yours anymore.. hehe wait til the troops show up.. ask me again.. peace
2/22/2013 10:29:50 AM 4

this is indeed starting to get interesting! cheapie
2/21/2013 1:09:19 AM 1

About 795,000 Americans each year suffer a new or recurrent stroke. That means, on average, a stroke occurs every 40 seconds. Stroke kills more than 137,000 people a year. That's about 1 of every 18 deaths. It's the No. 4 cause of death. ...
2/20/2013 8:23:16 PM 4

Hmmm, Sounds like the boomerang might be coming back. We changed the guard, changed the city, changed the mission of SCT, associated ourselves with great people, made advances toward novel approaches and procedures... and now here we are. NTx-265...
2/20/2013 3:35:32 PM 5

0.40 0.425 0.40 0.035 (9.59%) 34,160 eom
2/20/2013 11:14:47 AM

Stem Cell Therapeutics Corp NCT00938314 NTx®-265-CP-202-IS Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS-LED)
2/19/2013 8:23:21 PM 4

Stem Cell Therapeutics Announces Joint-Venture Agreement With Reneu Inc. and Nexgen Medical Systems, Inc Novel Combination of Neural Stem Cell Technology & Direct-to-Brain Administration of Therapeutics via an FDA-Cleared Neurocatheter Press ...
2/19/2013 5:13:58 PM 5

After making a ton of money on the last raisings, Mackie research has recently bought some shares after over a year of not buying any. could be a good sign. ten year net house, shows ANON(3m)/CIBC/MGI/MACKIE/CANACORD taking off with ~$4m, while T...
2/19/2013 2:17:13 PM

Market offering for March 1.
2/19/2013 9:29:39 AM

I tried myself to no avail. What did USA STEM consolidate at? They seem to have a pop today. Thanks. GLTA
2/12/2013 1:27:24 PM 5

I will admit to being 'surprised' by the unexpected rise in the stock price. I predicted that the SP would fall based on previous experience, and the fact that it's not working out that way this time, doesn't mean that the predict...
2/11/2013 1:01:57 AM 1
post non-threaded view
add to favorites
 
 
 
Today's Feature  
 
Pacific North West Capital Corp.
Pacific North West Capital Corp. (TSX: PFN; OTCQX: PAWEF; Frankfurt: P7J) is a mineral exploration company focused on the discovery, exploration and development of PGM and nickel-copper sulphide deposits in geologically prospective regions in North America, particularly Canada. The Company's key asset is its 100% owned River Valley PGM Project in the Sudbury region of northern Ontario. The River Valley Project is one of North America's most advanced primary PGM deposits...